Association of high-dose bifonazole administration during early pregnancy and severe limb reduction defects in the newborn

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 88, Issue 3, 2010, Pages 201-204

  Linder, Nehama ^a,b   Amarilla, Mandola ^a   Hernandez, Adriana ^a   Tamiri, Tsippy ^c   Sirota, Lea ^b,d   Klinger, Gil ^b,d   Levy, Itzhak ^d   Merlob, Paul ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c Israel Police   (Israel)

^d SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

Author keywords

Bifonazole; Limb defects; Teratogenicity

Indexed keywords

BIFONAZOLE; CLOTRIMAZOLE; VALERIAN;

ADULT; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG MEGADOSE; ECHOCARDIOGRAPHY; FEMALE; FIRST TRIMESTER PREGNANCY; HEART ATRIUM SEPTUM DEFECT; HUMAN; HYPOPLASIA; INFANT; LIMB REDUCTION DEFECT; MALE; NEWBORN; PHOCOMELIA; PHYSICAL EXAMINATION; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RESTLESSNESS; SLEEP DISORDER; VAGINA DISCHARGE; VAGINITIS;

ABNORMALITIES, DRUG-INDUCED; ABNORMALITIES, MULTIPLE; ANTIFUNGAL AGENTS; FEMALE; HUMANS; IMIDAZOLES; INFANT, NEWBORN; LIMB DEFORMITIES, CONGENITAL; MALE; MATERNAL EXPOSURE; RISK FACTORS;

EID: 77749327379     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.20644     Document Type: Article

References (29)

1. Aleck KA, Bartley DL. 1997. Multiple malformation syndrome following fluconazole use in pregnancy: report of and additional patient. Am J Med Genet 72:253-256.
2. Briggs GG, Freeman RK, Yaffe SJ. 2005. Itraconazole. In: Drugs in Pregnancy and Lactation, 7th ed, Lippincott, Williams and Wilkins, Philadelphia, pp. 869-870.
3. Byskov AG, Andersen CY, Nordholm L, et al. 1995. Chemical structure of sterols that activate oocyte meiosis. Nature 6522:559-562.
4. Carter TC, Druschel CM, Romitti PA, Bell EM, Werler MM, Mitchell AA. 2008. Antifungal drugs and the risk of selected birth defects. Am J Obstet Gynecol 198:191.e1-191.e7.
5. Cotman M, Jezek D, Fon Tacer K, Frangez R, Rozman D. 2004. A functional cytochrome P450 lanosterol 14 alpha-demethylase CYP51 enzyme in the acrosome: transport through the Golgi and synthesis of meiosis-activating sterols. Endocrinol 145:1419-1426.
6. Fukami M, Horikawa R, Nagai T, et al. 2005. Cytochrome P450 oxidoreductase gene mutations and Antley-Bixler syndrome with abnormal genitalia and/or impaired steroidogenesis: molecular and clinical studies in 10 patients. J Clin Endocrinol Metab 90:414-426.
7. Jick SS. 1999. Pregnancy outcomes after maternal exposure to fluconazole. Pharmacother 19:221-222.
8. Kazy Z, Puho E, Czeizel AE. 2005. The possible association between the combination of vaginal metronidazole and miconazole treatment and poly-syndactyly. Population-based case-control teratologic study. Reprod Toxicol 20:89-94.
9. King CT, Rogers PD, Clearly JD, Chapman SW. 1998. Antifungal therapy during pregnancy. Clin Infect Dis 27:1151-1160.
10. Kragie L, Turner SD, Patten CJ, et al. 2002. Assessing pregnancy risks of azole antifungals using a high throughput aromatase inhibition assay. Endocr Res 28:129-140.
11. Leachman SA, Reed BR. 2006. The use of dermatologic drugs in pregnancy and lactation. Dermatol Clin 24:167-197.
12. Lee BE, Feinberg M, Abraham JJ, Murthy AR. 1992. Congenital malformations in an infant born to a women treated with fluconazole. Pediatr Infect Dis J 11:1062-1064.
13. Lopez-Rangel E, Van Allen MI. 2005. Prenatal exposure to fluconazole: An identifiable dysmorphic phenotype. Birth Defects Res A Clin Mol Teratol 73:919-923.
14. Pursley TJ, Blomquist IK, Abraham J, et al. 1996. Fluconazole-induced congenital anomalies in three infants. Clin infect Dis 22: 336-340.
15. Reardon W, Smith A, Honour J, et al. 2000. Evidence for digenic inheritance in some cases of Antley-Bixler syndrome? J Med Genet 37:26-32.
16. Reproductive Toxicology Center. 2009a. Reproductive effects of chemical and biological agents (Reprotex). Available at: http://www.reprotox.org/Members/ PrintAgentDetail.aspx?a51129.Accessed September 2009.
17. Reproductive Toxicology Center. 2009b. Reproductive effects of chemical and biological agents (Reprotex). Available at: http://www.reprotox.org/Members/ PrintAgentDetail.aspx?a51133.Accessed September 2009.
18. Reproductive Toxicology Center. 2009c. Reproductive effects of chemical and biological agents (Reprotex). Available at: http://www.reprotox.org/Members/ printAgentDetail.aspx?a52676.Accessed September 2009.
19. Reproductive Toxicology Center. 2009d. Reproductive effects of chemical and biological agents (Reprotex) Available at: http://www.reprotox.org/Members/ PrintAgentDetail.aspx?a53236.Accessed September 2009.
20. Reproductive Toxicology Center. 2009e. Reproductive effects of chemical and biological agents (Reprotex). Available at: http://www.reprotox.org/Members/ PrintAgentDetail.aspx?a51113.Accessed September 2009.
21. Reproductive Toxicology Center. 2009f. Reproductive effects of chemical and biological agents (Reprotex). http://www.reprotox.org/Members/ PrintAgentDetail.aspx?a53236.Accessed September 2009.
22. Reproductive Toxicology Center. 2009g. Reproductive effects of chemical and biological agents (Reprotex). Available at: http://www.reprotox.org/Members/ PrintAgentDetail.aspx?a51133.Accessed September 2009.
23. Rosa FW, Baum C, Shaw M. 1987. Pregnancy outcomes after first-trimester vaginitis drug therapy. Obstet Gynecol 69:751-755.
24. Shepard TH, Lemire R. 2007. Catalog of teratogenic agents. 12th ed. Baltimore, MD: Johns Hopkins University Press.
25. Stromstedt M, Waterman MR, Haugen TB, et al. 1998. Elevated expression of lanosterol 14 alpha-demethylase (CYP51) and the synthesis of oocyte meiosis-activating sterols in postmeiotic germ cells of male rats. Endocrinol 139:2314-2321.
26. Tiboni GM. 2006. Defining critical periods for itraconazole-induced cleft palate, limb defects and axial skeletal malformations in the mouse. Toxicol Lett 167:8-18.
27. Waterham HR. 2002. Inherited disorders of cholesterol biosynthesis. Clin Genet 61:393-403.
28. Zahn JA. 2003. Azole fungicides affect mammalian steroidogenesis by inhibiting sterol 14 alpha-demethylase and aromatase 261. Environ Health Perspect 111:255-261.
29. Zhang W, Ramamoorthy Y, Kilicarslan T, et al. 2002. Inhibition of cytochromes P450 by antifungal imidazole derivatives. Drug Metab Dispos 30:314-318.